News Anklam Extrakt declaration of consent for newsletter subscription

Our free newsletter keeps you up to date with everything currently happening in our company. I consent to Anklam Extrakt GmbH sending me a newsletter from time to time, to the specified e-mail address. My personal data (surname, first name, e-mail address) may be stored and processed by Anklam Extrakt GmbH. We use rapidmail to distribute our newsletter. For this reason, your data are transmitted to rapidmail GmbH. rapidmail GmbH is prohibited from using your data for any other purposes than distributing the newsletter. With each newsletter, you are given the option of cancelling your subscription.

09/10/18

C² PHARMA and ANKLAM EXTRAKT^® announce R&D collaboration to develop cannabidiol-based compounds

C² PHARMA is implementing its cannabis strategy by collaborating with ANKLAM EXTRAKT®, a European-based manufacturer of botanical extracts with full GMP accreditations from the German authoriti ...

29/05/18

ANKLAM EXTRAKT wants to say thank you!

Dear reader, We are looking back happily to the Vitafoods Europe 2018 trade fair which was very eventful and successful for us. In addition to many interesting conversations, there were further highl ...

24/04/18

ANKLAM EXTRAKT goes Vitafoods Europe 2018 | April 2018

Dear reader, We are excited to see you at the Vitafoods Europe 2018 and would like to extend a warm welcome on our stand D39 . Our experts are pleased to inform you about Anklam Extrakt, our products, ...

01/09/17

Issue 23 | September 2017

Dear reader, we are on the way again and look forward to meeting you at where we will be represented with our own stand for the first time. We will be happy to provide you with more information abo ...